Applications are now open for the 2027 International Trainee Observership Programme organised by the American Society for Transplantation and Cellular Therapy (ASTCT). This competitive programme offers a unique opportunity for an international trainee from a low-income or lower-middle-income country to gain hands-on observational exposure in the field of hematopoietic cell transplantation (HCT) and related cellular therapies. The observership is hosted at the University of Illinois Chicago, providing participants with direct access to leading clinicians and researchers in transplantation medicine. Programme Overview and Purpose The observership is designed to strengthen global collaboration and improve clinical capacity in hematopoietic cell transplantation. It focuses on knowledge exchange and professional development for early-career clinicians working in resource-limited settings. The programme aims to: Foster international collaboration in HCT and cellular therapies Enhance clinical understanding of transplantation practices Support capacity building in low-resource healthcare systems Provide exposure to advanced transplant and cellular therapy programmes The selected scholar will observe clinical practice and academic discussions but will not participate in direct patient care. Placement Details The 2027 observership will take place over a four-week period at the University of Illinois Chicago. Location: University of Illinois Chicago, USA Dates: Monday, 22 February – Friday, 26 March 2027 Additional opportunity: Attendance at the 2027 Tandem Meetings of ASTCT & CIBMTR in Orlando, Florida Participants will gain exposure to both clinical and academic environments, including major international conferences in the field. Clinical Learning Areas During the observership, participants may observe a wide range of clinical and research activities, including: Diagnosis of hematologic disorders Pre-transplant evaluation and conditioning regimens Donor selection processes Stem cell collection and manipulation Outpatient post-transplant monitoring Development of clinical research in transplantation and cellular therapy This structured exposure provides insight into the full patient care pathway in HCT. Financial Support The programme is fully funded for the selected scholar. All major expenses are covered, including: Return international airfare Accommodation and lodging Meals and board Visa-related expenses Health insurance coverage This ensures equitable access for candidates from resource-limited settings. Eligibility Criteria Applicants must meet all of the following requirements to be considered: Hold a medical degree (MD, MBBS, DO or equivalent) Be a citizen and practising clinician in a low-income or lower-middle-income country (as classified by the World Bank) Be a trainee or junior faculty within five years of completing terminal training Be currently employed at a medical institution Have completed or be enrolled in training in: Hematology Oncology Immunology or Transplantation medicine The programme is specifically designed for early-career physicians working in clinical transplant-related fields. Application Requirements Applicants are required to submit the following documents: Curriculum Vitae (CV) Personal statement Letter of support from home institution Personal Statement must include: Experience in hematopoietic cell transplantation Expected learning outcomes from the observership Plans for implementing knowledge at the home institution Three specific objectives to be achieved through the programme The letter of support must confirm the applicant’s role and responsibilities in HCT practice at their institution. Application Process Applications are submitted through an online form and include both written responses and document uploads. Required sections include: Personal and professional details Training completion timeline Visa status for U.S. travel (for planning purposes only) Upload of CV Upload of personal statement Upload of institutional support letter Applicants must ensure all documents are complete and submitted before the deadline. Key Dates Application deadline: Sunday, 24 May 2026 Notification of results: Early July 2026 Observership period: 22 February – 26 March 2027 Late or incomplete applications will not be considered. Programme Value and Impact The observership offered by the American Society for Transplantation and Cellular Therapy provides early-career clinicians with rare exposure to advanced transplantation systems and research environments. Key benefits include: Direct observation of leading transplant clinical practice Interaction with global experts in cellular therapy Exposure to advanced clinical protocols and research methodologies Opportunities for professional networking and collaboration Knowledge transfer to strengthen home-country healthcare systems The programme is particularly valuable for clinicians seeking to develop or expand transplantation services in their home institutions. Conclusion The 2027 ASTCT International Trainee Observership Programme represents a fully funded opportunity for early-career physicians from resource-limited countries to gain advanced training exposure in hematopoietic cell transplantation. By combining clinical observation, academic engagement, and international networking, the programme supports global capacity building in a highly specialised area of medicine. VISIT OFFICIAL WEBSITE TO APPLY For more opportunities such as these please follow us on Facebook, Instagram, WhatsApp, Twitter, LinkedIn and WPChannel Disclaimer: Global South Opportunities (GSO) is not the organization offering the fellowship. For any inquiries, please contact the official organization directly. Please do not send your applications & CVs to GSO, as we are unable to process them. Due to the high volume of emails, we receive daily, we may not be able to respond to all inquiries. Thank you for your understanding.